» Articles » PMID: 20608959

Infantile Spasms: a U.S. Consensus Report

Overview
Journal Epilepsia
Specialty Neurology
Date 2010 Jul 9
PMID 20608959
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

The diagnosis, evaluation, and management of infantile spasms (IS) continue to pose significant challenges to the treating physician. Although an evidence-based practice guideline with full literature review was published in 2004, diversity in IS evaluation and treatment remains and highlights the need for further consensus to optimize outcomes in IS. For this purpose, a working group committed to the diagnosis, treatment, and establishment of a continuum of care for patients with IS and their families—the Infantile Spasms Working Group (ISWG)—was convened. The ISWG participated in a workshop for which the key objectives were to review the state of our understanding of IS, assess the scientific evidence regarding efficacy of currently available therapeutic options, and arrive at a consensus on protocols for diagnostic workup and management of IS that can serve as a guide to help specialists and general pediatricians optimally manage infants with IS. The overall goal of the workshop was to improve IS outcomes by assisting treating physicians with early recognition and diagnosis of IS, initiation of short duration therapy with a first-line treatment, timely electroencephalography (EEG) evaluation of treatment to evaluate effectiveness, and, if indicated, prompt treatment modification. Differences of opinion among ISWG members occurred in areas where data were lacking; however, this article represents a consensus of the U.S. approach to the diagnostic evaluation and treatment of IS.

Citing Articles

Liquid Medication Dosing Errors: Comparison of a Ready-to-Use Vigabatrin Solution to Reconstituted Solutions of Vigabatrin Powder for Oral Solution.

Gibson R, Klima R, Van Horn J Adv Ther. 2025; 42(3):1484-1493.

PMID: 39899223 PMC: 11868180. DOI: 10.1007/s12325-024-03089-0.


Infantile epileptic spasms syndrome: an etiologic study of 361 patients with infantile epileptic spasms syndrome.

Zhu L, Xia Y, Ding H, Zhang T, Li J, Li B Front Pediatr. 2025; 12():1522079.

PMID: 39850204 PMC: 11754263. DOI: 10.3389/fped.2024.1522079.


Efficacy and tolerability of celastrol and edaravone in the multiple-hit rat model of infantile spasms.

Shandra O, Wang Y, Coles L, Mowrey W, Li Q, Liu W Epilepsy Behav. 2024; 162:110159.

PMID: 39577370 PMC: 11681605. DOI: 10.1016/j.yebeh.2024.110159.


IGF-1 impacts neocortical interneuron connectivity in epileptic spasm generation and resolution.

Ballester-Rosado C, Le J, Lam T, Anderson A, Frost Jr J, Swann J Neurotherapeutics. 2024; 22(1):e00477.

PMID: 39516073 PMC: 11743118. DOI: 10.1016/j.neurot.2024.e00477.


Study on the gut microbiota, HPA, and cytokine levels in infantile spasms.

You J, Liu L, Pan X, Wu L, Tan L, Zhou C Front Immunol. 2024; 15:1442677.

PMID: 39450173 PMC: 11499101. DOI: 10.3389/fimmu.2024.1442677.